ARTICLE | Company News
Cel-Sci, Aptiv Solutions, Ergomed deal
October 26, 2015 7:00 AM UTC
Cel-Sci and Ergomed amended an April 2013 deal and Ergomed will increase to $12 million from $10 million its contribution to the ongoing Phase III trial of Cel-Sci’s Multikine in patients with advanc...